Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE; AMENDMENT REFERENCES.
(a) SHORT TITLE.—This Act may be cited as the
‘‘National Narcotics Leadership Act Amendments of
1997’’.
(b) AMENDMENT REFERENCES.—Except as other-
wise expressly provided, whenever in this Act an amend-
ment or repeal is expressed in terms of an amendment
to, or repeal of, a section or other provision, the reference
shall be considered to be made to a section or other provi-
sion of the National Narcotics Leadership Act of 1988 (21
U.S.C. 1501 et seq.).
SEC. 2. DEPUTY DIRECTORS.
(a) ESTABLISHMENT.—Section 1002 (21 U.S.C.
1501) is amended—
(1) in subsection (b)—
(A) by amending paragraph (2) to read as
follows:
‘‘(2) There shall be in the Office of National Drug
Control Policy a Deputy Director of the Office of National
Drug Control Policy, a Deputy Director for Demand Re-
duction, a Deputy Director for Supply Reduction, a Dep-
uty Director for State and Local Affairs, and a Deputy
Director of Intelligence.’’; and
(B) by amending paragraph (3) to read as
follows:
‘‘(3) The Deputy Director of the Office of National
Drug Control Policy, the Deputy Director for Demand Re-
duction, the Deputy Director for Supply Reduction, the
Deputy Director for State and Local Affairs, and the Dep-
uty Director of Intelligence shall assist the Director in car-
rying out the responsibilities of the Director under this
Act.’’; and
(2) by amending subsection (c)(2) to read as
follows:
‘‘(2) The Deputy Director for State and Local Affairs
shall be the head of the Bureau of State and Local Af-
fairs.’’.
(b) APPOINTMENT.—
(1) IN GENERAL.—Section 1003(a) (21 U.S.C.
1502(a)) is amended—
(A) in each of paragraphs (1) and (2), by
inserting ‘‘the Deputy Director of the Office of
National Drug Control Policy,’ after ‘‘The Di-
rector,’’;
(B) in each of paragraphs (1) and (2), by
striking ‘‘and the Associate Director for Na-
tional Drug Control Policy’’ and inserting ‘‘the
Deputy Director for State and Local Affairs,
and the Deputy Director of Intelligence’’; and
(C) in paragraph (2), by striking ‘‘, a Dep-
uty Director, or Associate Director’’ and insert-
ing ‘‘or as a Deputy Director’’.
(2) DEADLINE FOR NOMINATION.—The Presi-
dent shall submit to the Senate nominations of indi-
viduals for appointment as the Deputy Director of
the Office of National Drug Control Policy, the Dep-
uty Director for Demand Reduction, the Deputy Di-
rector for Supply Reduction, the Deputy Director for
State and Local Affairs, and the Deputy Director of
Intelligence of the Office of National Drug Control
Policy by not later than 90 days after the date of
the enactment of this Act.
(3) CONTINUED SERVICE OF ASSOCIATE DIREC-
TOR.—The individual serving on the date of the en-
actment of this Act as Associate Director for Na-
tional Drug Control Policy may act as the Deputy
Director for State and Local Affairs until such time
as an individual is appointed to that position in ac-
cordance with the amendments made by this Act.
(4) CLERICAL
AMENDMENT.—The heading of
section 1003 (21 U.S.C. 1502) is amended to read
as follows:
‘‘SEC. 1003. APPOINTMENT AND DUTIES OF DIRECTOR AND
DEPUTY DIRECTORS.’’.
(c) COMPENSATION.—
(1) IN GENERAL.—Chapter 53 of title 5, United
States Code, is amended—
(A) in section 5314, by inserting after the
item relating to the Deputy Director for Supply
Reduction, Office of National Drug Control
Policy, the following:
‘‘Deputy Director for State and Local Affairs,
Office of National Drug Control Policy.
‘‘Deputy Director of Intelligence, Office of Na-
tional Drug Control Policy.’’;
(B) in section 5313, by adding at the end
the following:
‘‘Deputy Director of the Office of National
Drug Control Policy.’’; and
(C) in section 5315, by striking the item
relating to the Associate Director for National
Drug Control Policy, Office of National Drug
Control Policy.
(2) CLERICAL AMENDMENT.—Section 1003(a)
(21 U.S.C. 1502(a)) is amended by striking para-
graph (4)(C).
SEC. 3. EXPANSION OF RESPONSIBILITIES OF DIRECTOR.
(a) EXPANSION
OF
RESPONSIBILITIES.—Section
1003(b) (21 U.S.C. 1502(b)) is amended—
(1) by amending paragraph (1) to read as fol-
lows:
‘‘(1) establish Federal policies, objectives, goals,
priorities, and performance measures (including spe-
cific annual agency targets expressed in terms of
precise percentages) for the National Drug Control
Program and for each National Drug Control Pro-
gram agency, which include targets for the following:
‘‘(A) reduction of unlawful drug use to 3
percent of the population of the United States
or less by December 31, 2001 (as measured in
terms of overall illicit drug use during the past
30 days by the National Household Survey),
and achievement of at least 25 percent of such
reduction during each of 1998, 1999, 2000, and
2001;
‘‘(B) reduction of adolescent unlawful drug
use (as measured in terms of illicit drug use
during the past 30 days by the Monitoring the
Future Survey of the University of Michigan or
the National PRIDE Survey conducted by the
National Parents’ Resource Institute for Drug
Education) to 3 percent of the adolescent popu-
lation of the United States or less by December
31, 2001, and achievement of at least 25 per-
cent of such reduction during each of 1998,
1999, 2000, and 2001;
‘‘(C) reduction of the availability of co-
caine, heroin, marijuana, and methamphet-
amine in the United States by 80 percent by
December 31, 2001;
‘‘(D) reduction of the respective nationwide
average street purity levels for cocaine, heroin,
marijuana, and methamphetamine (as esti-
mated by the interagency drug flows assessment
led by the Office of National Drug Control Pol-
icy, and based on statistics collected by the
Drug Enforcement Administration and other
National Drug Control Program agencies iden-
tified as relevant by the Director) by 60 percent
by December 31, 2001, and achievement of at
least 25 percent of each such reduction during
each of 1998, 1999, 2000, and 2001;
‘‘(E) reduction of drug-related crime in the
United States by 50 percent by December 31,
2001, and achievement of at least 25 percent of
such reduction during each of 1998, 1999,
2000, and 2001, including—
‘‘(i) reduction of State and Federal
unlawful drug trafficking and distribution;
‘‘(ii) reduction of State and Federal
crimes committed by persons under the in-
fluence of unlawful drugs; and
‘‘(iii) reduction of State and Federal
crimes committed for the purpose of ob-
taining unlawful drugs or obtaining prop-
erty that is intended to be used for the
purchase of unlawful drugs; and
‘‘(F) reduction of drug-related emergency
room incidents in the United States (as meas-
ured by data of the Drug Abuse Warning Net-
work on illicit drug abuse), including incidents
involving gunshot wounds and automobile acci-
dents in which illicit drugs are identified in the
bloodstream of the victim, by 50 percent by De-
cember 31, 2001;’’;
(2) by amending paragraph (3) to read as fol-
lows:
‘‘(3) coordinate, oversee, and evaluate the effec-
tiveness of the implementation of the policies, objec-
tives, goals, performance measures, and priorities es-
tablished under paragraph (1) and the fulfillment of
the responsibilities of the National Drug Control
Program agencies under the National Drug Control
Strategy;’’;
(3) in paragraph (5), by inserting ‘‘and non-
governmental entities involved in demand reduction’’
after ‘‘governments’’;
(4) by striking ‘‘and’’ at the end of paragraph
(7);
(5) by striking the period at the end of para-
graph (8) and inserting a semicolon; and
(6) by adding at the end the following new
paragraphs:
‘‘(9) require each National Drug Control Pro-
gram agency to submit to the Director on a semi-
annual basis (beginning with the first 6 months of
1998) an evaluation of progress by the agency with
respect to drug control program goals using the per-
formance measures referred to in paragraph (1), in-
cluding progress with respect to—
‘‘(A) success in reducing domestic and for-
eign sources of illegal drugs;
‘‘(B) success in protecting the borders of
the United States (and in particular the South-
western border of the United States) from pen-
etration by illegal narcotics;
‘‘(C) success in reducing violent crime as-
sociated with drug use in the United States;
‘‘(D) success in reducing the negative
health and social consequences of drug use in
the United States; and
‘‘(E) implementation of drug treatment
and prevention programs in the United States
and improvements in the adequacy and effec-
tiveness of such programs;
‘‘(10) submit to Congress on a semi-annual
basis, not later than 60 days after the date of the
last day of the applicable 6-month period, a sum-
mary of—
‘‘(A) each of the evaluations received by
the Director under paragraph (9); and
‘‘(B) the progress of each National Drug
Control Program agency toward the drug con-
trol program goals of the agency using the per-
formance measures described in paragraph (1);
‘‘(11) require the National Drug Control Pro-
gram agencies to submit to the Director not later
than February 1 of each year a detailed accounting
of all funds expended by the agencies for National
Drug Control Program activities during the previous
fiscal year, and require such accounting to be au-
thenticated by the Inspector General for each agency
prior to submission to the Director;
‘‘(12) submit to Congress not later than April
1 of each year the information submitted to the Di-
rector under paragraph (11);
‘‘(13) submit to Congress not later than August
1 of each year a report including—
‘‘(A) the budget guidance provided by the
Director to each National Drug Control Pro-
gram agency for the fiscal year in which the re-
port is submitted and for the other fiscal years
within the applicable five-year budget plan re-
lating to such fiscal year; and
‘‘(B) a summary of the request of each
National Drug Control Program agency to the
Director under this Act (prior to review of the
request by the Office of Management and
Budget) for the resources required to achieve
the targets of the agency under this Act;
‘‘(14) act as a representative of the President
before Congress on all aspects of the National Drug
Control Program;
‘‘(15) act as the primary spokesperson of the
President on drug issues;
‘‘(16) make recommendations to National Drug
Control Program agency heads with respect to im-
plementation of Federal counter-drug programs;
‘‘(17) take such actions as necessary to oppose
any attempt to legalize the use of a substance (in
any form) that—
‘‘(A) is listed in schedule I of section 202
of the Controlled Substances Act (21 U.S.C.
812); and
‘‘(B) has not been approved for use for
medical purposes by the Food and Drug Ad-
ministration; and
‘‘(18) ensure that drug prevention and drug
treatment research and information is effectively dis-
seminated by National Drug Control Program agen-
cies to State and local governments and nongovern-
mental entities involved in demand reduction by—
‘‘(A) encouraging formal consultation be-
tween any such agency that conducts or spon-
sors research, and any such agency that dis-
seminates information in developing research
and information product development agendas;
‘‘(B) encouraging such agencies (as appro-
priate) to develop and implement dissemination
plans that specifically target State and local
governments and nongovernmental entities in-
volved in demand reduction; and
‘‘(C) developing a single interagency clear-
inghouse for the dissemination of research and
information by such agencies to State and local
governments and nongovernmental agencies in-
volved in demand reduction.’’.
(b) SURVEY OF DRUG USE.—(1) The University of
Michigan shall not be prohibited under any law from con-
ducting the survey of drug use among young people in the
United States known as the Monitoring the Future Sur-
vey.
(2) The National Parents’ Resource Institute for
Drug Education in Atlanta, Georgia, shall not be prohib-
ited under any law from conducting the survey of drug
use among young people in the United States known as
the National PRIDE Survey.
SEC. 4. EXPANSION OF POWERS OF DIRECTOR.
Section 1003(d) (21 U.S.C. 1502(d)) is amended—
(1) in paragraph (9), by striking the period and
inserting a semicolon; and
(2) by adding at the end the following new
paragraphs:
‘‘(10) require the heads of National Drug Con-
trol Program agencies to provide the Director with
statistics, studies, reports, and any other informa-
tion regarding Federal control of drug abuse;
‘‘(11) require the heads of National Drug Con-
trol Program agencies to provide the Director with
information regarding any position (before an indi-
vidual is nominated for such position) that—
‘‘(A) relates to the National Drug Control
Program;
‘‘(B) is at or above the level of Deputy As-
sistant Secretary; and
‘‘(C) involves responsibility for Federal
counternarcotics or anti-drug programs; and
‘‘(12) make recommendations to the National
Drug Intelligence Center on the specific projects
that the Director determines will enhance the effec-
tiveness of implementation of the National Drug
Control Strategy.’’.
SEC. 5. SUBMISSION OF NATIONAL DRUG CONTROL STRAT-
EGY.
(a) IN GENERAL.—Section 1005(a) is amended—
(1) by amending paragraph (2)(A) to read as
follows:
‘‘(A) include comprehensive, research-based,
specific, long-range goals and performance measures
(including specific annual targets expressed in terms
of precise percentages) for reducing drug abuse and
the consequences of drug abuse in the United
States;’’;
(2) by striking ‘‘and’’ at the end of paragraph
(2)(C);
(3) by striking paragraph (2)(D);
(4) by adding at the end of paragraph (2) the
following new paragraphs:
‘‘(D) include 4-year projections for National
Drug Control Program priorities (including budget
priorities); and
‘‘(E) review international, Federal, State, local,
and private sector drug control activities to ensure
that the United States pursues well-coordinated and
effective drug control at all levels of government.’’;
(5) in paragraph (3)(A), by striking clauses (iv)
and (v) and inserting the following:
‘‘(iv) private citizens and organizations with ex-
perience and expertise in demand reduction;
‘‘(v) private citizens and organizations with ex-
perience and expertise in supply reduction; and
‘‘(vi) appropriate representatives of foreign gov-
ernments.’’;
(6) in paragraph (4)—
(A) in subparagraph (B), by amending
clauses (i) through (vi) to read as follows:
‘‘(i) the quantities of cocaine, heroin, mari-
juana, methamphetamine, ecstasy, and rohypnol
available for consumption in the United States;
‘‘(ii) the amount of cocaine, heroin, mari-
juana, ecstasy, rohypnol, methamphetamine,
and precursor chemicals entering the United
States;
‘‘(iii) the number of hectares of marijuana,
poppy, and coca cultivated and destroyed do-
mestically and in other countries;
‘‘(iv) the number of metric tons of mari-
juana, cocaine, heroin, and methamphetamine
seized;
‘‘(v) the number of cocaine and meth-
amphetamine processing labs destroyed domes-
tically and in other countries;
‘‘(vi) changes in the price and purity of
heroin and cocaine, changes in price of meth-
amphetamine, 
and 
changes 
in
tetrahydrocannabinol level of marijuana;’’;
(B) by striking ‘‘and’’ at the end of sub-
paragraph (C);
(C) by striking the period at the end sub-
paragraph (D) and inserting ‘‘; and’’; and
(D) by adding at the end the following new
subparagraph:
‘‘(E) assessment of the cultivation of illegal
drugs in the United States.’’; and
(7) in paragraph (5)—
(A) in the matter preceding subparagraph
(A), by striking ‘‘February 1, 1995’’ and insert-
ing ‘‘February 1, 1998’’;
(B) in the matter preceding subparagraph
(A), by striking ‘‘second’’;
(C) by striking ‘‘and’’ at the end of sub-
paragraph (C);
(D) by striking the period at the end of
subparagraph (D) and inserting ‘‘; and’’; and
(E) by adding at the end the following new
subparagraph:
‘‘(E) a description of the National Drug Con-
trol Program performance measures described in
subsection (a)(2)(A).’’.
(b) GOALS AND PERFORMANCE MEASURES FOR NA-
TIONAL DRUG CONTROL STRATEGY.—Section 1005(b) is
amended—